Overview
Announcements

Ordinary Reweighting | Several Solactive Indices | Effective Date 8th June 2023

Enhanced Consciousness Index:

In the ordinary rebalance, the following index composition will be implemented effective open 08.06.2023:

ACADIA PHARMACEUTICALS INC
ALKERMES PLC
ATAI LIFE SCIENCES B.V
BIOGEN INC
CEREVEL THERAPEUTICS HOLDINGS INC
COMPASS PATHWAYS PLC
DENALI THERAPEUTICS INC
GH RESEARCH PLC
H LUNDBECK AS – Class B
INTRA-CELLULAR THERAPIES INC
JAZZ PHARMACEUTICALS PLC
JOHNSON & JOHNSON
KARUNA THERAPEUTICS INC
MIND MEDICINE MINDMED INC
MYRIAD GENETICS INC
NEUROCRINE BIOSCIENCES INC
NRX PHARMACEUTICALS INC
PTC THERAPEUTICS INC
RELMADA THERAPEUTICS INC.
SAGE THERAPEUTICS INC
SAREPTA THERAPEUTICS INC
SEELOS THERAPEUTICS INC
TONIX PHARMACEUTICALS HOLDIN
UCB SA
VISTAGEN THERAPEUTICS INC

Enhanced Consciousness Index:

In the ordinary rebalance, the following index composition will be implemented effective open 08.06.2023:

ACADIA PHARMACEUTICALS INC
ALKERMES PLC
ATAI LIFE SCIENCES B.V
BIOGEN INC
CEREVEL THERAPEUTICS HOLDINGS INC
COMPASS PATHWAYS PLC
DENALI THERAPEUTICS INC
GH RESEARCH PLC
H LUNDBECK AS – Class B
INTRA-CELLULAR THERAPIES INC
JAZZ PHARMACEUTICALS PLC
JOHNSON & JOHNSON
KARUNA THERAPEUTICS INC
MIND MEDICINE MINDMED INC
MYRIAD GENETICS INC
NEUROCRINE BIOSCIENCES INC
NRX PHARMACEUTICALS INC
PTC THERAPEUTICS INC
RELMADA THERAPEUTICS INC.
SAGE THERAPEUTICS INC
SAREPTA THERAPEUTICS INC
SEELOS THERAPEUTICS INC
TONIX PHARMACEUTICALS HOLDIN
UCB SA
VISTAGEN THERAPEUTICS INC